康比特 833429 2024 官微二维码 年度报告 （如有） 可视化年报 （如有） 1 北京康比特体育科技股份有限公司 公司年度大事记 1、2024 年 1 月，北京市体育局、北京市人力资源和社会保障局做出《关于表彰 2020-2023 年度北京市体育事业突出贡献 奖先进集体和先进个人的决定》，公司总经理李奇庚女士被授予"2020-2023 年度北京市体育事业突出贡献奖先进个人"的 称号。 2、2024 年 2 月，在教育部、高校毕业生就业协会等单位的指导下，由康比特、北京体育大学、广州城市职业学院等单位 共同发起的数字化运动健康营养行业产教融合共同体成立大会在广州召开。 3、2024 年 2 月，由康比特与广州城市职业学院携手申办的一带一路暨金砖国家技能发展与技术创新大赛"数字化运动营 养咨询与指导"赛项在广州城市职业学院成功举办。 4、2024 年 3 月，首都精神文明建设委员会办公室发布了《首都文明单位名单》，康比特被授予"首都文明单位"称号。 5、2024 年 3 月，在 2024 年 IWF 上海国际健身展，康比特推出体重管理新品燃享和全新升级的乳清蛋白 ultra 产品，并荣 获"营养食品技术创 ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.1000 | 0.0900 | 11.11 | 0.0900 | | 每股净资产（元） | 6.88 | 6.5 | 5.85 | 6.03 | | 每股公积金(元) | 2.23 | 2.23 | 0 | 2.24 | | 每股未分配利润(元) | 3.32 | 2.81 | 18.15 | 2.38 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.94 | 1.54 | 25.97 | 1.31 | | 净利润(亿元) | 0.12 | 0.11 | 9.09 | 0.11 | | 净资产收益率(%) | 1.39 | 1.37 | 1.46 | 1.44 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 6455.26万股，累计占流通股比： 56.97%，较上期变化： 16 ...

Core Insights - 康比特智慧营养健康餐厅 launched at the 33rd Shanghai International Hotel and Catering Industry Expo, showcasing its "AI Sports Nutritionist" app integrated with DeepSeek model, aligning with the national "Weight Management Year" initiative [1][8] - The restaurant emphasizes personalized nutrition management based on individual health goals, addressing common health issues such as weight loss, muscle gain, and high uric acid levels [3][5] - 康比特's AI platform offers a balanced approach to nutrition and exercise, allowing users to offset excess calorie intake through exercise recommendations, promoting individualized health management [5][7] Industry Trends - The integration of AI technology in dietary services marks a shift from traditional methods to digital solutions, enhancing the quality of nutrition services for both athletes and the general public [8][10] - 康比特's initiative represents a new paradigm in employee welfare, where companies invest in health through digitalized canteen services, enabling employees to manage their health autonomously [10][12] - The use of professional body composition analysis tools at the expo highlights the importance of data-driven personalized nutrition services, which are crucial for effective health management [12][14] Product Features - 康比特智慧营养健康餐厅 offers AI nutrition advice, smart health management, and personalized nutrition reports, attracting significant industry attention [14] - The restaurant's immersive dining experience allows guests to engage with AI-driven meal planning, showcasing the potential for deeper integration of technology in the food service industry [14]

证券代码：833429 证券简称：康比特 公告编号：2025-015 北京康比特体育科技股份有限公司 回购股份达到 1%暨回购股份结果公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律 责任。 一、 回购方案基本情况 （一） 审议情况 北京康比特体育科技股份有限公司（以下简称"公司"）于 2024 年 8 月 26 日召 开第六届董事会第七次会议、第六届监事会第七次会议，审议通过《关于公司回购股 份方案的议案》；公司于 2025 年 2 月 10 日召开第六届董事会第十次会议，审议通过 了《关于调整股份回购价格上限及延长实施期限的议案》。根据《北京证券交易所上 市公司持续监管指引第 4 号——股份回购》《公司章程》等相关规则制度规定，前述 事项均无需提交股东大会审议。 （二） 回购股份的目的 基于对公司未来发展的信心和对公司价值的认可，提升公司股票长期投资价值， 综合考虑公司经营情况、财务状况以及未来的盈利能力等因素，公司拟以自有资金回 购公司股份。本次回购的股份将用于实施股权激励，以此进一步完善公司治理结构 ...

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Insights - The recent signing of marathon runner Jiaorenjia as a brand ambassador is expected to enhance brand recognition and consumer trust, potentially driving sales [7] - The marathon industry in China is experiencing significant growth, with an increase in the number of events and participants, supported by favorable policies [7] - The company is actively developing a comprehensive product matrix to cater to runners' needs, including energy supplements and recovery products [7] - The company is building a running ecosystem to foster customer loyalty and encourage repeat purchases through sponsorship of events and partnerships with running groups [7] - The financial forecasts for the company remain stable, with projected net profits of 0.89 billion, 1.15 billion, and 1.56 billion for 2024, 2025, and 2026 respectively, indicating strong growth potential [7] Financial Data and Profit Forecast - Total revenue is projected to grow from 843 million in 2023 to 1,873 million by 2026, with a compound annual growth rate (CAGR) of approximately 33.2% [3] - The net profit attributable to the parent company is expected to increase from 88 million in 2023 to 156 million in 2026, reflecting a CAGR of around 35.1% [3] - Earnings per share (EPS) is forecasted to rise from 0.71 in 2023 to 1.25 in 2026 [3] Market Data - As of March 26, 2025, the closing price of the stock is 19.09, with a price-to-earnings (PE) ratio of 27 [4] - The company has a market capitalization of 2,163 million [4] - The stock has a dividend yield of 1.05% based on the most recent dividend announcement [4]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The weight management industry is identified as a golden growth track, with significant potential driven by increasing health consciousness and supportive policies [6][11] - The company is strategically positioning itself to capitalize on the booming weight management sector, aiming to establish it as a third growth pillar alongside its existing business lines [6][11] - The report slightly raises profit forecasts for 2024-2026, reflecting positive business developments and market conditions [6] Financial Data and Profit Forecast - Total revenue projections are as follows: 2023: 843 million, 2024E: 1,041 million, 2025E: 1,406 million, 2026E: 1,873 million, with growth rates of 32.8%, 23.4%, 35.0%, and 33.2% respectively [5] - Net profit forecasts are: 2024E: 89 million, 2025E: 115 million, 2026E: 156 million, with growth rates of 1.6%, 28.7%, and 35.1% respectively [5] - Earnings per share are projected to be 0.72, 0.93, and 1.25 for 2024E, 2025E, and 2026E respectively [5] - The price-to-earnings ratio is expected to be 26, 20, and 15 for the years 2024E, 2025E, and 2026E respectively [5] Industry Insights - The weight management sector is characterized by a large domestic consumer base and strong demand, with projections indicating that the number of overweight/obese individuals in China will exceed 500 million by 2030 [6][12] - The report highlights the increasing trend of health-conscious consumption among younger demographics, particularly women, who are prioritizing fitness and wellness [20][21] - The company is launching a new sub-brand, CPTfit, targeting the female market with a focus on high-protein products, which aligns with current consumer trends [6][11] Policy and Market Dynamics - The government is actively promoting weight management initiatives, with a national plan set to enhance public awareness and improve lifestyle habits [51][54] - The report draws parallels with Japan's weight management industry, emphasizing the role of government support in fostering market growth and innovation [54][56]

北 交 所 研 究 康比特（833429.BJ） 北交所信息更新 2025 年 03 月 13 日 投资评级：买入（维持） | 日期 | 2025/3/13 | | --- | --- | | 当前股价(元) | 20.97 | | 一年最高最低(元) | 24.36/8.28 | | 总市值(亿元) | 26.11 | | 流通市值(亿元) | 23.76 | | 总股本(亿股) | 1.25 | | 流通股本(亿股) | 1.13 | | 近 3 个月换手率(%) | 148.9 | 北交所研究团队 能量胶等爆品增长较快，2024 年扣非净利润同比+15% ——北交所信息更新 诸海滨（分析师） zhuhaibin@kysec.cn 证书编号：S0790522080007 2024 年业绩快报：营收 10.41 亿元、归母净利润 8949.95 万元 公司发布 2024 年业绩快报，实现营收 10.41 亿元，同比增长 23.44%；归母净利 润 8949.95 万元，同比增长 1.59%；扣非净利润 8735.37 万元，同比增长 15.32%。 公司坚持走高端、差异化的竞争路线，充分发挥品牌、技术研发、 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][4] Core Insights - The company reported a revenue of 1.041 billion yuan for 2024, representing a year-on-year growth of 23.44%, and a net profit attributable to shareholders of 89.5 million yuan, which is a 1.59% increase year-on-year [4][5] - The company is focusing on high-end, differentiated competition, leveraging its brand, technology research and development, and sales channels to create value [4] - The forecast for net profit attributable to shareholders for 2024-2026 is adjusted to 89 million, 123 million, and 142 million yuan respectively, with corresponding EPS of 0.72, 0.99, and 1.14 yuan per share [4][5] Financial Performance Summary - Revenue and net profit projections for 2024-2026 are as follows: - Revenue: 1.041 billion (2024), 1.248 billion (2025), 1.518 billion (2026) - Net profit: 89 million (2024), 123 million (2025), 142 million (2026) - Year-on-year growth rates for revenue are projected at 23.5% (2024), 19.8% (2025), and 21.7% (2026) [5][10] - The company’s gross margin is expected to be around 39.8% in 2024, with a slight increase to 40.8% in 2025 and 40.9% in 2026 [10][11] Market Strategy - The company plans to increase sponsorship of outdoor events such as cycling, hiking, and team sports to enhance brand visibility and consumer loyalty [6] - The strategy includes linking events with e-commerce promotions to drive product sales effectively [6]

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance in the near future [6]. Core Insights - The company has demonstrated strong revenue growth driven by innovation, with a projected revenue increase from 8.43 billion CNY in 2023 to 15.90 billion CNY by 2026, reflecting a compound annual growth rate (CAGR) of approximately 24.22% [2][8]. - The net profit attributable to shareholders is expected to grow from 0.88 billion CNY in 2023 to 1.35 billion CNY in 2026, with a notable profit growth rate of 52.92% in 2023, followed by more moderate growth in subsequent years [2][8]. - The company is actively expanding its production capacity, increasing its investment in the "Sports Nutrition Food Production Base" from 126 million CNY to 309 million CNY, which will enhance its market position and supply capabilities [6][8]. Financial Forecast Summary - **Revenue Forecast**: - 2023: 8.43 billion CNY - 2024: 10.41 billion CNY (growth rate: 23.46%) - 2025: 12.80 billion CNY (growth rate: 22.96%) - 2026: 15.90 billion CNY (growth rate: 24.22%) [2][8] - **Net Profit Forecast**: - 2023: 0.88 billion CNY - 2024: 0.89 billion CNY (growth rate: 1.58%) - 2025: 1.11 billion CNY (growth rate: 23.61%) - 2026: 1.35 billion CNY (growth rate: 22.11%) [2][8] - **Earnings Per Share (EPS)**: - 2023: 0.71 CNY - 2024: 0.72 CNY - 2025: 0.89 CNY - 2026: 1.09 CNY [2][8] Market Position and Product Innovation - The company is focusing on continuous product innovation, with the introduction of new formulations and flavors, which is expected to significantly boost sales in the sports nutrition sector [6][8]. - The sports nutrition market in China is still developing, with low penetration rates, indicating substantial growth potential for the company as consumer awareness and demand for nutritional supplements increase [6][8].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance in the near future [6]. Core Insights - The company has demonstrated strong revenue growth driven by innovation, with a projected revenue increase from 8.43 billion yuan in 2023 to 15.90 billion yuan by 2026, reflecting a compound annual growth rate (CAGR) of approximately 24.22% [2][6]. - The net profit attributable to shareholders is expected to grow from 0.88 billion yuan in 2023 to 1.35 billion yuan in 2026, with a notable profit growth rate of 52.92% in 2023, followed by more moderate growth in subsequent years [2][6]. - The company is actively expanding its production capacity, increasing its investment in the "Sports Nutrition Food Production Base" from 126 million yuan to 309 million yuan, which will enhance its market position and supply capabilities [6][8]. Financial Forecast Summary - **Revenue Forecast**: - 2023: 8.43 billion yuan - 2024: 10.41 billion yuan (growth rate: 23.46%) - 2025: 12.80 billion yuan (growth rate: 22.96%) - 2026: 15.90 billion yuan (growth rate: 24.22%) [2][8] - **Net Profit Forecast**: - 2023: 0.88 billion yuan - 2024: 0.89 billion yuan (growth rate: 1.58%) - 2025: 1.11 billion yuan (growth rate: 23.61%) - 2026: 1.35 billion yuan (growth rate: 22.11%) [2][8] - **Earnings Per Share (EPS)**: - 2023: 0.71 yuan - 2024: 0.72 yuan - 2025: 0.89 yuan - 2026: 1.09 yuan [2][8] - **Price-to-Earnings (P/E) Ratio**: - 2024: 25.37 - 2025: 20.53 - 2026: 16.81 [2][8]